N S G Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.15 M
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.59 M
- Revenue Growth 36.07%
- Profit Growth 26.80%
- Ebitda 26.81%
- Net Worth 4.52%
- Total Assets 5.57%
About N S G Biotech
N S G Biotech Private Limited (NSGBPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 October 2014 and has a history of Ten years and four months. Its registered office is in Patna, Bihar, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.15 M.
The company currently has active open charges totaling ₹0.59 M.
Gaurav Tiwary and Raushni Tiwary serve as directors at the Company.
Company Details
- Location
Patna, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33125BR2014PTC023040
- Company No.
023040
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Oct 2014
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Who are the key members and board of directors at N S G Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Tiwary  | Managing Director | 08-Oct-2014 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raushni Tiwary | Director | 22-Jun-2023 | Current |
Financial Performance of N S G Biotech.
N S G Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 36.07% increase. The company also saw a substantial improvement in profitability, with a 26.8% increase in profit. The company's net worth moved up by a moderate rise of 4.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of N S G Biotech?
In 2015, N S G Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.59 M
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Nov 2022 | Indian Bank | ₹0.59 M | Open |
How Many Employees Work at N S G Biotech?
Unlock and access historical data on people associated with N S G Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of N S G Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped N S G Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
